ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Risk factors for immune checkpoint inhibitor-related interstitial lung disease: a retrospective cohort study.

Takahiro Amemiya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.